Bioceres Crop Solutions Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
$0.20next fiscal year
Monitoring Framework
Key Performance Indicators
Consolidated Gross Margin (Continuing Operations) Quarterly4,000.0%Target: Maintain or exceed 40% through cost realignment and high-value proprietary product sales
Quarterly Revenue (Continuing Operations) Quarterly39.4MTarget: Stabilize and reverse the 23% YoY decline by scaling Crop Nutrition and HB4 Seeds
Net Financial Debt Quarterly214MTarget: Reduce leverage through working capital discipline and debt reprofiling
Watch Items
- Going Concern Uncertainty & Debt RefinancingTrigger: Failure to secure long-term refinancing with local Argentine financial institutions or execute asset disposalsAction: Monitor progress of Rizobacter Argentina S.A. debt reprofiling and voluntary bond maturity extensions.
- Pro Farm Foreclosure Litigation & Transition AgreementTrigger: Crystallization of residual debt position following the $15 million credit bid on $194 million of net assetsAction: Track legal proceedings, counterclaims, and the finalization of the transition agreement with noteholders.
- HB4 Technology Platform AdoptionTrigger: Slower-than-expected regulatory approvals or farmer trial results in new geographies (e.g., U.S. and Brazil)Action: Evaluate quarterly Seed and Integrated Products segment revenue contribution and commercial launch milestones.
Research as of 19 Jun 2026